Yadav KS, Rajpurohit R, Sharma S. Glaucoma: current treatment and impact of advanced drug delivery systems. Life Sci. 2019;221:362–76. https://doi.org/10.1016/j.lfs.2019.02.029.

Article  PubMed  Google Scholar 

Yadav KS, Sharma S, Londhe VY. Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma. Life Sci. 2020;243:117303. https://doi.org/10.1016/j.lfs.2020.117303.

Article  PubMed  Google Scholar 

Peral A. Contact lenses as drug delivery system for glaucoma: a review. Appl Sci. 2020;10(15):5151. https://doi.org/10.3390/app10155151.

Article  Google Scholar 

Sartini F. In vivo efficacy of contact lens drug-delivery systems in glaucoma management. A systematic review. Appl Sci. 2021;11(2):724. https://doi.org/10.3390/app11020724.

Article  Google Scholar 

Maulvi FA, Shetty KH, Desai DT, Shah DO, Willcox MDP. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration. Int J Pharm. 2021;608:121105. https://doi.org/10.1016/j.ijpharm.2021.121105.

Article  PubMed  Google Scholar 

Oh DJ, Chen JL, Vajaranant TS, Dikopf MS. Brimonidine for the treatment of glaucoma. Expert Opin Pharmacother. 2019;20:115–22. https://doi.org/10.1080/14656566.2018.1544241.

Article  PubMed  Google Scholar 

Cantor LB. Brimnidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag. 2006;2(4):337–46. https://doi.org/10.2147/2Ftcrm.2006.2.4.337.

Article  PubMed  PubMed Central  Google Scholar 

Alyami H. Nonionic surfactant vesicles (niosomes) for ocular drug delivery: Development, evaluation and toxicological profiling. J Drug Deliv Sci Technol. 2020;60:102069. https://doi.org/10.1016/j.jddst.2020.102069.

Article  Google Scholar 

Kumar N, Aggarwal R, Chauhan KM. Extended levobunolol release from Eudragit nanoparticle-laden contact lenses for glaucoma therapy. Future J Pharm Sci. 2020;6:109. https://doi.org/10.1186/s43094-020-00128-9.

Article  Google Scholar 

Fathala D, Fouad EA, Soliman GM. Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma. Drug Dev Ind Pharm. 2020;46:806–13. https://doi.org/10.1080/03639045.2020.1755305.

Article  Google Scholar 

Xu J, Ge Y, Bu R. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma. J Control Release. 2019;305:18–28. https://doi.org/10.1016/j.jconrel.2019.05.025.

Article  PubMed  Google Scholar 

Xu W, Wanzhen J. Bimatoprost loaded microemulsion laden contact lens to treat glaucoma. J Drug Deliv Sci Technol. 2019;54:101330. https://doi.org/10.1016/j.jddst.2019.101330.

Article  Google Scholar 

Maulvi FA, Patil RJ, Desai AR, Shukla MR, Vaidya RJ, Ranch KM, Vyas BA, Shah SA, Shah DO. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation. Acta Biomater. 2019;86:350–62. https://doi.org/10.1016/j.actbio.2019.01.004.

Article  PubMed  Google Scholar 

Kumar GP, Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery—an overview. Acta Pharm Sin B. 2011;1(4):208–19. https://doi.org/10.1016/j.apsb.2011.09.002.

Article  Google Scholar 

Verma A. Emerging potential of niosomes in ocular delivery. Expert Opin Drug Deliv. 2021;18:55–71. https://doi.org/10.1080/17425247.2020.1822322.

Article  PubMed  Google Scholar 

Gugleva V, Titeva S. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system. Int J Pharm. 2019;567:118431. https://doi.org/10.1016/j.ijpharm.2019.06.022.

Article  PubMed  Google Scholar 

Gupta P, Yadav KS. Formulation and evaluation of brinzolamide encapsulated niosomal in-situ gel for sustained reduction of IOP in rabbits. J Drug Deliv Sci Technol. 2022;67:103004. https://doi.org/10.1016/j.jddst.2021.103004.

Article  Google Scholar 

Moiseev RV, Morrison PW. Penetration enhancers in ocular drug delivery. Pharmaceutics. 2019;11(7):321. https://doi.org/10.3390/2Fpharmaceutics11070321.

Article  PubMed  PubMed Central  Google Scholar 

Waqas MK, Sadia H. Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches. Des Monomers Polym. 2022;2022:165–74. https://doi.org/10.1080/2F15685551.2022.2086411.

Article  Google Scholar 

Khan DH, Bashir S. Process optimization of ecological probe sonication technique for production of rifampicin loaded niosomes. J Drug Deliv Sci Technol. 2019;50:27–33. https://doi.org/10.1016/j.jddst.2019.01.012.

Article  Google Scholar 

Verma P, Yadav KS. Quality by design (QbD) enabled and Box-Behnken design assisted approach for formulation of tranexamic acid loaded stratum corneum lipid liposomes. J Drug Deliv Sci Technol. 2023;86:104571. https://doi.org/10.1016/j.jddst.2023.104571.

Article  Google Scholar 

Silva LD, Htar TT. Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes. Int J Nanomed. 2019;14:1101–17. https://doi.org/10.2147/2FIJN.S184912.

Article  Google Scholar 

Singh KH, Shinde UA. Chitosan nanoparticles for controlled delivery of Brimonidine to the ocular membrane. Pharmazie. 2011;66:594–9. https://doi.org/10.1691/ph.2011.0349.

Article  PubMed  Google Scholar 

Bayindir ZS, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. AAPS PharmSciTech. 2012;13:826–35. https://doi.org/10.1208/2Fs12249-012-9805-4.

Article  Google Scholar 

Mohamad EA, Fahmy HM. Niosomes and liposomes as promising carriers for dermal delivery of Annona squamosa extract. Braz J Pharm Sci. 2020;56:e18096. https://doi.org/10.1590/s2175-97902019000318096.

Article  Google Scholar 

Eldeeb AE, Salah S, Ghorab M. Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of Brimonidine; formulation, in-vitro characterization, and in-vivo pharmacodynamic study. Drug Deliv. 2019;26:509–21. https://doi.org/10.1080/10717544.2019.1609622.

Article  Google Scholar 

Zheng J, Clogston DJ, Patri AK. Dobrovolskaia AM, McNeil SE. Sterilization of silver nanoparticles using standard gamma irradiation procedure affects particle integrity and biocompatibility. J Nanomed Nanotechnol 2011:95–101. https://doi.org/10.4172/2F2157-7439.S5-001.

Padala S, Sripada R, Gundabattula SB, Tadi KJ, Nallamothula PR, Raveshi F, Magharla DD. A comparative study on the efficacy of brinzolamide/timolol versus brinzolamide/brimonidine fixed drug combinations in primary open-angle glaucoma. Future J Pharm Sci. 2020;6(1):1–7.

Google Scholar 

Dubey A, Prabhu P. Development and investigation of niosomes of Brimonidine and timolol maleate for the treatment of glaucoma. Int J PharmTech Res. 2014;6(3):942–50.

Google Scholar 

Maulvi FA, Soni TG, Shah DO. A review on therapeutic contact lenses for ocular drug delivery. Drug Deliv. 2016;23:3017–26. https://doi.org/10.3109/10717544.2016.1138342.

Article  PubMed  Google Scholar 

Maulvi FA, et al. Controlled bimatoprost release from graphene oxide laden contact lenses: in vitro and in vivo studies. Colloids Surf B. 2020;208:112096. https://doi.org/10.1016/j.colsurfb.2021.112096.

Article  Google Scholar 

Jung HJ, Jaoude MA. Glaucoma therapy by extended release of timolol from nanoparticle loaded. J Control Rel. 2012;2012:82–9. https://doi.org/10.1016/j.jconrel.2012.10.010.

Article  Google Scholar 

Nguyen DC. Pharmaceutical-loaded contact lenses as an ocular drug delivery system: A review of critical lens characterization methodologies with reference to ISO standards. Cont Lens Anterior Eye. 2021;44(6):101487. https://doi.org/10.1016/j.clae.2021.101487.

Article  PubMed  Google Scholar 

Pereira-da-Mota AF, Lopez MV. Atorvastatin-eluting contact lenses: effects of molecular imprinting and sterilization on drug loading and release. Pharmaceutics. 2021;13(5):606. https://doi.org/10.3390/pharmaceutics13050606.

Article  PubMed  PubMed Central  Google Scholar 

Gulsen D, Li CC, Chauhan A. Dispersion of DMPC liposomes in contact lenses for opthalmic drug delivery. Curr Eye Res. 2005;30:1071–80. https://doi.org/10.1080/02713680500346633.

Article  PubMed  Google Scholar 

Jain N, Verma A, Jain N. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits. Drug Deliv. 2020;27:888–99. https://doi.org/10.1080/10717544.2020.1775726.

Article  PubMed  PubMed Central  Google Scholar 

Elshaer A, et al. Nanoparticle-laden contact lens for controlled ocular delivery of prednisolone: Formulation optimization using statistical experimental design. Pharmaceutics. 2016;8(2):14. https://doi.org/10.3390/pharmaceutics8020014.

Article  PubMed  PubMed Central  Google Scholar 

Basiri L, Rajabzadeh G, Bostan A. α-Tocopherol-loaded niosome prepared by heating method and its release behavior. Food Chem. 2017;221:620–8. https://doi.org/10.1016/j.foodchem.2016.11.129.

Article  PubMed  Google Scholar 

Abdelkader H, Ismail S, Kamal A, Alany RG. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: Physicochemical characterization. Pharmazie. 2010;65:811–7.

PubMed  Google Scholar 

Souza JF, Maia KN. Ocular inserts based on chitosan and Brimonidine: development, characterization and biocompatibility. J Drug Deliv Sci Technol. 2016:21–30. https://doi.org/10.1016/j.jddst.2016.01.008.

Pramod K, Ali J. Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies. Jo Anal Sci Technol. 2015. https://doi.org/10.1186/s40543-015-0073-2.

Article  Google Scholar 

Mohamed HB, El-Shanawany SM, Hamad MA, Elsabahy M. Niosomes: a strategy toward prevention of clinically significant drug incompatibilities. Sci Rep. 2017;7(1):6340. https://doi.org/10.1038/s41598-017-06955-w.

Article  PubMed  PubMed Central  Google Scholar 

Sharma PK, Chauhan MK. Optimization and characterization of Brimonidine Nanoparticles-loaded in situ gel for